-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Regencell Bioscience Holdings Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q2 2024 to Q2 2025.
- Regencell Bioscience Holdings Ltd Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending June 30, 2025 was $336K, a 436% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)